Target-selective phototherapy using a ligand-based photosensitizer for type 2 cannabinoid receptor.

ABSTRACT: Phototherapy is a powerful, noninvasive approach for cancer treatment, with several agents currently in clinical use. Despite the progress and promise, most current phototherapy agents have serious side effects as they can lead to damage to healthy tissue, even when the photosensitizers are fused to targeting molecules due to nonspecific light activation of the unbound photosensitizer. To overcome these limitations, we developed a phototherapy agent that combines a functional ligand and a near infrared phthalocyanine dye. Our target is type 2 cannabinoid receptor (CB2R), considered an attractive therapeutic target for phototherapy given it is overexpressed by many types of cancers that are located at a surface or can be reached by an endoscope. We show that our CB2R-targeted phototherapy a

SUBMITTER: Zhang S 

PROVIDER: S-EPMC3989837 | biostudies-literature | 2014 Mar

REPOSITORIES: biostudies-literature